Concepedia

Charlotte Joly

CJ

Statistics

Publications

2

Citations

37

H-Index

2

Active since

2018

Affiliations

Inserm(Current)

Centre Léon Bérard

Institut Paoli-Calmettes

Centre François Baclesse

Institut Gustave Roussy

Charlotte Joly is an author at Inserm specializing in oncology, cancer therapeutics, and urology.

ORCID

Top concepts

Publications per year

2018–2023

2

Publications

2

Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study

Aline Guillot, Charlotte Joly, Philippe Barthélémy et al. · Clinical Genitourinary Cancer · 2018 · 19 citations

, , +7

Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)

Constance Thibault, Aude Fléchon, Laurence Albigès et al. · European Journal of Cancer · 2023 · 18 citations

, , +6

1–2 of 2